Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farhad Asarzadegan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Caspian Journal of Internal Medicine|May 24, 2023
Trigeminal neuralgia: IncobotulinumtoxinA (Xeomin), can it decrease the pharmacological intervention? (A case series)Meghdad Hosseini, Farhad Asarzadegan, Erfan Shafiee, et al.
Archives of Academic Emergency Medicine|December 26, 2019
Validation of SUSPEKT Score in Predicting One-month Mortality of Patients with Hemorrhagic Stroke; a Diagnostic Accuracy StudyHamid Kariman, Hamidreza Hatamabadi, Majid Shojaee, et al.
Drug Development Research|February 28, 2020
Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosisNikoo Hossein-Khannazer, Samira Shabani, Mohadeseh Farokhfar, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Caspian Journal of Internal Medicine|May 24, 2023
Trigeminal neuralgia: IncobotulinumtoxinA (Xeomin), can it decrease the pharmacological intervention? (A case series)Meghdad Hosseini, Farhad Asarzadegan, Erfan Shafiee, et al.
Archives of Academic Emergency Medicine|December 26, 2019
Validation of SUSPEKT Score in Predicting One-month Mortality of Patients with Hemorrhagic Stroke; a Diagnostic Accuracy StudyHamid Kariman, Hamidreza Hatamabadi, Majid Shojaee, et al.
Drug Development Research|February 28, 2020
Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosisNikoo Hossein-Khannazer, Samira Shabani, Mohadeseh Farokhfar, et al.
Pageof 1